Hjem › Adenokarcinom i spiserøret › Ohio
Kliniske studier for Adenokarcinom i spiserøret i Ohio
12 studier for Adenokarcinom i spiserøret søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Miami Valley Hospital South, Centerville
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- og 3 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Strecker Cancer Center-Belpre, Belpre
- Miami Valley Hospital South, Centerville
- Adena Regional Medical Center, Chillicothe
- og 30 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Local Institution - 0443, Cleveland
- Local Institution - 0222, Cleveland
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07221149Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- og 1 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07392892Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 50 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06687603Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
- Case Western Reserve University, Cleveland
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Cleveland VA Medical Research and Education Foundation, Cleveland
- University Hospitals Cleveland Medical Center Case Western University, Cleveland
- Cleveland Clinic Foundation, Cleveland
Rekrutterer
Alder 18 til 89 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Columbus
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07431281A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- University of Cincinnati Cancer Center, Cincinnati
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07544589A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Maumee
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07182149Obeticholic Acid for Prevention in Barrett's Esophagus
- Case Western Reserve University, Cleveland
- Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland
- University Hospitals Cleveland Medical Center, Cleveland
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT04939051First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Cleveland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT07284186Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.